Open Access<p>Physical Activity versus Sclerostin and Interleukin 6 Concentration in Patients Receiving Renal Replacement Therapy by Hemodialysis</p>
Author(s) -
Agnieszka Turoń-Skrzypińska,
Grażyna Dutkiewicz,
Małgorzata Marchelek-Myśliwiec,
Aleksandra Rył,
Violetta Dziedziejko,
Krzysztof Safranow,
Kazimierz Ciechanowski,
Iwona Rotter
Publication year - 2020
Publication title -
risk management and healthcare policy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.828
H-Index - 22
ISSN - 1179-1594
DOI - 10.2147/rmhp.s255780
Subject(s) - medicine , hemodialysis , nephrology , dialysis , waist , renal replacement therapy , kidney disease , mann–whitney u test , anthropometry , statistical significance , physical therapy , gastroenterology , body mass index
Chronic kidney disease and renal replacement therapy are associated with reduced motor activity, which may result in the presence of mineral bone disorders and an increase in inflammation markers. The aim of the study was to assess the relationship between the performance of daily physical activity, expressed in the number of steps performed by patients undergoing hemodialysis and the concentration of selected biochemical parameters (SCL, IL-6).